747149
Last Update Posted: 2011-08-31
Recruiting has ended
All Genders accepted | 18 Years + |
598 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Diabetes Study to Treat A Population Previously Not at Target
This study will assess if customizing the start dose of rosuvastatin appropriate for the degree of LDL-C reduction required, would achieve LDL-C target of ≤ 2.0 mmol/L quickly with either no titration or just one titration step after 6 weeks of therapy in type 2 diabetic patients previously treated with another statin and not at LDL-C targets.
Eligibility
Relevant conditions:
Type 2 Diabetes
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov